Daoib for dementia

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 3 Oct 2022: Trial started, NCT05582161
  2. 17 Oct 2022: Trial registered, NCT05582161

The trials

NCT05582161: Efficacy Biomarkers of DAOIB for Dementia

State
Under way
Phase
Phase 2
People
123 planned
Started
3 Oct 2022
Primary completion
Sep 2026
Arms
DAOIB
Results
None posted
  1. 3 Oct 2022: Trial started
  2. 17 Oct 2022: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.